Sarepta Therapeutics (SRPT) EV to FCF (2020 - 2026)
Sarepta Therapeutics' EV to FCF was 13.56 in Q2 2026, down 5.3% from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) EV to FCF (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sarepta Therapeutics' EV to FCF was -16.30 through Jun 30, 2026; for FY2020, it came in at 458.55.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Sarepta Therapeutics | 1.92 Bn | -1.31 Bn | 251.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.56 |
| Mar 31, 2026 | 14.31 |
| Dec 31, 2020 | 458.55 |
| Sep 30, 2020 | 195.09 |
| Jun 30, 2020 | 44.90 |
| Mar 31, 2020 | 20.54 |
API Access
Sarepta Therapeutics EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();